ReviewBMJ global health2025
Tuberculosis at the crossroads: urgent actions for migrant and refugee health in a turbulent era.
Review in BMJ global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Prevalence and associated factors with presumptive tuberculosis in the war-torn Tigray, Ethiopia: a community-based comparative study.Journal of clinical tuberculosis and other mycobacterial diseases · 2026Article
- Tuberculosis Care Access Among Internally Displaced Persons in India and Nigeria: A Review of Structural Barriers and Context-Specific Interventions.Public health challenges · 2026Review
- Asymptomatic Tuberculosis: The Silent Face of the Disease Among Migrants and Refugees and the Challenges in Brazil.Journal of immigrant and minority health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Tuberculosis (TB) remains the world's deadliest infectious disease kiler, affecting the most vulnerable, including refugees and migrants. Their vulnerability is intensified by structural and social barriers that hinder diagnosis and treatment and restrict healthcare access. To put a spotlight on this issue, the WHO in collaboration with the Qatar Foundation launched a technical report on innovative solutions for TB elimination among refugees and migrants at the Seventh World Innovation Summit for Health (WISH) in November 2024. The report proposes 10 policy options and includes seven illustrative case studies to address the issue of TB among refugees and migrants. The global public health landscape has shifted dramatically since the report's release. Widespread funding cuts for health and development coupled with escalating geopolitical tensions now threaten hard-won public health gains. On the back of an already chronically underfunded TB response, where only 26% of the needed funds were available, both global and local responses to TB are faltering-putting lives, equity and elimination goals at serious risk. While the 2024 WISH report outlined policy actions to address TB among refugees and migrants, shrinking funding for health and development now threatens implementation. Therefore, in this analysis piece, we examine the current and urgent challenge of addressing TB among migrants and refugees framed in the context of three policy actions in the WISH report-namely, political commitment, adequate resourcing and equitable access to healthcare. We argue that sustaining and scaling up efforts to end TB is not optional-it is imperative.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.